周五(11月8日)股市交易中,医疗器械制造商百特国际(BAX.N)盘中股价一度大跌5.11%,最低跌至34.18美元/股,成为医疗行业表现最差的个股。引发百特国际股价重挫的主因是该公司再次下调了2024年财年的业绩指引预期。
百特公司预计,由于前期飓风灾害导致生产线遭受损失,第四季度销售额将减少约2亿美元。在此影响下,该公司调整全年每股收益预期区间为2.90-2.94美元,较之前2.93-3.01美元的目标有所下调,并且低于分析师预期的2.95美元。
此前公布的第三季度财报数据也令投资者失望,百特公司当季利润为每股0.80美元,低于预期的每股0.78美元。不佳的业绩表现和未来前景引发投资者担忧,在周五的交易中抛售该股股票。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.